Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax<sup>®</sup> tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study-Reference-Cited by-同舟云学术

Bioequivalence of generic alendronate sodium tablets (70 mg) to Fosamax^® tablets (70 mg) in fasting, healthy volunteers: a randomized, open-label, three-way, reference-replicated crossover study

Published:2017-07 Issue: Volume:Volume 11 Page:2109-2119
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Zhang Yifan^ORCID,Chen Xiaoyan,Tang Yunbiao,Lu Youming,Guo Lixia,Zhong Dafang

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput analysis of alendronate in human samples with derivatization-free hydrophilic-interactive chromatography mass spectrometry;Journal of Pharmaceutical and Biomedical Analysis;2024-01

2. Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia;European Journal of Clinical Pharmacology;2023-11-02

3. Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model;Biomolecules;2023-08-26

4. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study;Advances in Therapy;2021-08-04

5. Pharmacogenetic perspectives in improving pharmacokinetic profiles for efficient bioequivalence trials with highly variable drugs: a review;International Journal of Pharmacokinetics;2021-03